IDEAYA Biosciences, Inc. Common Stock
$29.33
USD
Last updated on --.
24h volume590.76K
24h highest29.4950 USD
24h lowest28.5801 USD
24h Price movement+0.81%
IDYA recent prices
24 Hours
+0.81%+$0.235
30 days
-1.54%-$0.455
60 days
-4.50%-$1.370
90 days
-9.01%-$2.875
Key data
Previous close29.1000 USD
Market cap2.61B USD
Volume590.76K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-1.5900 USD
Net income (FY)-140.06M USD
Revenue (FY)225.27M USD
Last report date5 May 2026
About IDEAYA Biosciences, Inc. Common Stock
HeadquartersSOUTH SAN FRANCISCO
Employees (FY)145.00
Revenue per employee (FY)1.55M USD
Net income per employee (FY)-965.92K USD
Listed onNasdaq
IDYA conversion tables
 |  |
|---|---|
| 0.5 IDYA | 14.66 USD |
| 1 IDYA | 29.33 USD |
| 5 IDYA | 146.67 USD |
| 10 IDYA | 293.35 USD |
| |
|---|---|
| 0.5 USD | 0.017044 IDYA |
| 1 USD | 0.034089 IDYA |
| 5 USD | 0.17044 IDYA |
| 10 USD | 0.34089 IDYA |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
IDYA is trading at $29.33, +0.81% over the last 24 hours. Track live moves on the price chart at the top of this page.
The IDYA stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. IDYA is currently trading at $29.33, +0.81% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on IDYA price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. IDYA's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from IDYA; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against IDYA's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
IDEAYA Biosciences, Inc. Common Stock's market cap is currently 2.61B USD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume590.76K
24h highest29.4950 USD
24h lowest28.5801 USD
24h Price movement+0.81%
Start trade with IDYA Perpetual
Sign up to trade